Shamburg News · 8-K filed Nov 18, 2026, 5:24 PM EST
NexGel Appoints Aviv Argaman to Board; Forms Special Committee on Proposed Merger
NXGL · NEXGEL, INC.
- Leadership change
- Other event
- Acquisition
- Materiality: high
On November 12, 2026, NexGel's Board elected Aviv Argaman as an independent director, and on November 18, 2026, appointed him to a newly formed special committee of independent directors. The committee was established to evaluate and negotiate the proposed Merger with Fountainhead LifeSciences and its affiliates, which the Company states has not yet reached a definitive agreement. Mr. Argaman, through Asymmetry Point, holds Notes that would convert into Common Stock upon completion of the Merger.
Source: SEC EDGAR, Form 8-K, Items 5.02, 8.01, accession 0001493152-26-053107.
Written from the filing by Shamburg Markets. Figures are as reported by the company.